According to Kezar Life Sciences's latest financial reports the company's current earnings (TTM) are -$0.11 B. In 2022 the company made an earning of -$68.24 M a decrease over its 2021 earnings that were of -$54.63 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.11 B | 49.28% |
2022 | -$68.24 M | 24.91% |
2021 | -$54.63 M | 30.88% |
2020 | -$41.75 M | 18.97% |
2019 | -$35.09 M | 51.45% |
2018 | -$23.17 M | 172.01% |
2017 | -$8.52 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 8.75% | ๐บ๐ธ USA |